| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76882-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-77188-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-64867-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76689-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-77010SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NB100-65535-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76569-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76741-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-77139-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-70385 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-71326 | |||
![Western Blot: Bcl-10 Antibody [NBP1-76882] - Raji whole cell lysate in the absence (A) or presence (B) of peptide (2161P) with Bcl-10 antibody at 1:500 dilution.](http://images.novusbio.com/fullsize/Bcl-10-Antibody-Western-Blot-NBP1-76882-img0001.jpg "Western Blot: Bcl-10 Antibody [NBP1-76882] - Raji whole cell lysate in the absence (A) or presence (B) of peptide (2161P) with Bcl-10 antibody at 1:500 dilution.")
![Immunocytochemistry/ Immunofluorescence: Bcl-10 Antibody - BSA Free [NBP1-76882] - Immunofluorescence of Bcl-10 in Raji cells with Bcl-10 antibody at 10 u/mL.](http://images.novusbio.com/fullsize/nbp1-76882_rabbit-polyclonal-bcl-10-antibody-2711202420352463.jpg)
![Immunocytochemistry/ Immunofluorescence: Bcl-10 Antibody - BSA Free [NBP1-76882] - Immunocytochemistry of Bcl10 in Raji cells with Bcl10 antibody at 1 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76882_rabbit-polyclonal-bcl-10-antibody-2711202420392725.jpg)
![Western Blot: SCRN2 Antibody [NBP1-77188] - 293 cell tissue lysate with SCRN2 antibody at (A) 0.5 and (B) 1 ug/mL.](http://images.novusbio.com/fullsize/SCRN2-Antibody-Western-Blot-NBP1-77188-img0001.jpg "Western Blot: SCRN2 Antibody [NBP1-77188] - 293 cell tissue lysate with SCRN2 antibody at (A) 0.5 and (B) 1 ug/mL.")
![Immunocytochemistry/ Immunofluorescence: SCRN2 Antibody - BSA Free [NBP1-77188] - Immunocytochemistry of SCRN2 in 293 cells with SCRN2 antibody at 20 ug/mL.](http://images.novusbio.com/fullsize/nbp1-77188_rabbit-polyclonal-scrn2-antibody-271120242016966.jpg)
![Immunocytochemistry/ Immunofluorescence: SCRN2 Antibody - BSA Free [NBP1-77188] - Immunofluorescence of SCRN2 in 293 cells with SCRN2 antibody at 20 ug/mL.](http://images.novusbio.com/fullsize/nbp1-77188_rabbit-polyclonal-scrn2-antibody-2711202419432264.jpg)
![Flow Cytometry: CD28 Antibody (YTH913.12) [NB100-64867] - Analysis using the PE conjugate of NB100-64867. Staining of human peripheral blood lymphocytes.](http://images.novusbio.com/fullsize/CD28-Antibody-YTH913-12-Flow-Cytometry-NB100-64867-img0007.jpg "Flow Cytometry: CD28 Antibody (YTH913.12) [NB100-64867] - Analysis using the PE conjugate of NB100-64867. Staining of human peripheral blood lymphocytes.")
![Flow Cytometry: CD28 Antibody (YTH913.12) [NB100-64867] - Staining of human peripheral blood lymphocytes with Rat anti Human.](http://images.novusbio.com/fullsize/CD28-Antibody-YTH913-12-Flow-Cytometry-NB100-64867-img0003.jpg)
![Flow Cytometry: CD28 Antibody (YTH913.12) [NB100-64867] - Staining of human peripheral blood lymphocytes with Rat anti Human.](http://images.novusbio.com/fullsize/CD28-Antibody-YTH913-12-Flow-Cytometry-NB100-64867-img0004.jpg)
![Flow Cytometry: CD28 Antibody (YTH913.12) [NB100-64867] - Analysis using the Biotin conjugate of NB100-64867. Staining of human peripheral blood lymphocytes.](http://images.novusbio.com/fullsize/CD28-Antibody-YTH913-12-Flow-Cytometry-NB100-64867-img0006.jpg)
![Western Blot: HVEM/TNFRSF14 Antibody [NBP1-76689] - Raji cell lysate with TNFRSF14 antibody at 2 u/mL in (A) the absence and (B) the presence of blocking peptide.](http://images.novusbio.com/fullsize/HVEM-TNFRSF14-Antibody-Western-Blot-NBP1-76689-img0001.jpg "Western Blot: HVEM/TNFRSF14 Antibody [NBP1-76689] - Raji cell lysate with TNFRSF14 antibody at 2 u/mL in (A) the absence and (B) the presence of blocking peptide.")
![Immunocytochemistry/ Immunofluorescence: HVEM/TNFRSF14 Antibody - BSA Free [NBP1-76689] - Immunofluorescence of HVEM/TNFRSF14 in Raji cells with HVEM/TNFRSF14 antibody at 20 u/mL.](http://images.novusbio.com/fullsize/nbp1-76689_rabbit-polyclonal-hvem-tnfrsf14-antibody-2711202420352412.jpg)
![Immunocytochemistry/ Immunofluorescence: HVEM/TNFRSF14 Antibody - BSA Free [NBP1-76689] - Immunocytochemistry of HVEM/TNFRSF14 in Raji with HVEM/TNFRSF14 antibody at 10 u/mL.](http://images.novusbio.com/fullsize/nbp1-76689_rabbit-polyclonal-hvem-tnfrsf14-antibody-2711202420352442.jpg)
![Western Blot: HVEM/TNFRSF14 Antibody - BSA Free [NBP1-76689] - Western blot analysis of 5 ng of HVEM/TNFRSF14 with HVEM/TNFRSF14 antibody at 1 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76689_rabbit-polyclonal-hvem-tnfrsf14-antibody-2711202420171720.gif)
![Western Blot: DFF45/ICAD Antibody [NBP1-77010] - Analysis of ICAD in murine lung tissue lysate with ICAD antibody at 1 ug/ml.](http://images.novusbio.com/fullsize/DFF45-ICAD-Antibody-Western-Blot-NBP1-77010-img0005.jpg "Western Blot: DFF45/ICAD Antibody [NBP1-77010] - Analysis of ICAD in murine lung tissue lysate with ICAD antibody at 1 ug/ml.")
![Immunocytochemistry/ Immunofluorescence: DFF45/ICAD Antibody - BSA Free [NBP1-77010] - Immunofluorescence of DFF45/ICAD in Mouse Lung cells with DFF45/ICAD antibody at 10 ug/mL.](http://images.novusbio.com/fullsize/nbp1-77010_rabbit-polyclonal-dff45-icad-antibody-2711202420212313.jpg)
![Immunohistochemistry: DFF45/ICAD Antibody - BSA Free [NBP1-77010] - Immunohistochemistry of DFF45/ICAD in mouse lung tissue with DFF45/ICAD antibody at 2 ug/mL.](http://images.novusbio.com/fullsize/nbp1-77010_rabbit-polyclonal-dff45-icad-antibody-2711202419172245.jpg)
![Immunohistochemistry: CD44 Antibody (VFF-17) - variant 7/8 [NB100-65535] - Analysis of representative areas of synovial tissue samples taken from patients with end-stage osteoarthritis (OA) or refractory rheumatoid arthritis (RA) is shown. Expression pattern and staining intensity of RA samples represent the stronger intensity of synovial inflammation when compared with OA samples.](http://images.novusbio.com/fullsize/CD44-Antibody-VFF-17-variant-7-8-Immunohistochemistry-NB100-65535-img0003.jpg "Immunohistochemistry: CD44 Antibody (VFF-17) - variant 7/8 [NB100-65535] - Analysis of representative areas of synovial tissue samples taken from patients with end-stage osteoarthritis (OA) or refractory rheumatoid arthritis (RA) is shown. Expression pattern and staining intensity of RA samples represent the stronger intensity of synovial inflammation when compared with OA samples.")
![Immunohistochemistry: CD44 Antibody (VFF-17) - variant 7/8 [NB100-65535] - Analysis of activation markers in synovial membranes of osteoarthritis. Phenotypic markers that are instrumental in extracellular matrix alteration are detectable only at a low level (MMP-1, CD44v7/8) in areas that are slightly FAP-positive. FAP, fibroblast activation protein; MMP, matrix metalloproteinase.](http://images.novusbio.com/fullsize/CD44-Antibody-VFF-17-variant-7-8-Immunohistochemistry-NB100-65535-img0001.jpg)
![Immunohistochemistry: CD44 Antibody (VFF-17) - variant 7/8 [NB100-65535] - Analysis of activation markers in synovial membranes of rheumatoid arthritis. Expression of fibroblast activation protein (FAP) is accompanied by accumulation of activation markers (MMP-1 and MMP-13) and splice variants of CD44 (v3 and v7/8) that are known to correlate with the degree of inflammation and that are involved in extracellular matrix deposition.](http://images.novusbio.com/fullsize/CD44-Antibody-VFF-17-variant-7-8-Immunohistochemistry-NB100-65535-img0002.jpg)
![Western Blot: ROCK1 Antibody [NBP1-76569] - 293 cell lysate with ROCK1 antibody at 1 ug/mL in (A) the absence and (B) the presence of blocking peptide.](http://images.novusbio.com/fullsize/ROCK1-Antibody-Western-Blot-NBP1-76569-img0001.jpg "Western Blot: ROCK1 Antibody [NBP1-76569] - 293 cell lysate with ROCK1 antibody at 1 ug/mL in (A) the absence and (B) the presence of blocking peptide.")
![Immunocytochemistry/Immunofluorescence: ROCK1 Antibody [NBP1-76569] - Immunofluorescence of ROCK1 in 293 cells with ROCK1 antibody at 20 ug/mL.](http://images.novusbio.com/fullsize/ROCK1-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-76569-img0002.jpg)
![Immunocytochemistry/ Immunofluorescence: ROCK1 Antibody - BSA Free [NBP1-76569] - Immunocytochemistry of ROCK1 in 293 cells with ROCK1 antibody at 10 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76569_rabbit-polyclonal-rock1-antibody-271120242010585.jpg)
![Western Blot: PERP Antibody [NBP1-76741] - Western Blot Validation in Human A431 whole cell lysates in the Absence (A) and Presence (B) of Blocking Peptide. Loading: 15 ug of lysates per lane. Antibodies: PERP NBP1-76741 (1 ug/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/PERP-Antibody-Western-Blot-NBP1-76741-img0006.jpg "Western Blot: PERP Antibody [NBP1-76741] - Western Blot Validation in Human A431 whole cell lysates in the Absence (A) and Presence (B) of Blocking Peptide. Loading: 15 ug of lysates per lane. Antibodies: PERP NBP1-76741 (1 ug/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.")
![<b>Independent Antibodies Validation. </b>Western Blot: PERP Antibody [NBP1-76741] - Independent Antibody Validation via Protein Expression Profile in Human Cell Lines. Loading: 15 ug lysates per lane. Antibodies: PERP NBP1-76741 (1ug/ml), PERP antibody from Company B (2 ug/ml), beta-actin NBP1-76692 (1 ug/ml) and GAPDH (0.02 ug/ml), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/PERP-Antibody-Western-Blot-NBP1-76741-img0004.jpg)
![Western Blot: PERP Antibody [NBP1-76741] - Western Blot Validation in Human Cell Lines. Loading: 15 ug of lysates per lane. Antibodies: PERP NBP1-76741 (1 ug/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/PERP-Antibody-Western-Blot-NBP1-76741-img0005.jpg)
![Immunocytochemistry/ Immunofluorescence: PERP Antibody - BSA Free [NBP1-76741] - Validation of PERP in A431 Cells. Immunocytochemical analysis of A431 cells using anti-PEPR antibody at 10 ug/ml. Cells was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.](http://images.novusbio.com/fullsize/nbp1-76741_rabbit-polyclonal-perp-antibody-271120241923644.jpg)
![Western Blot: MAEL Antibody [NBP1-77139] - HeLa cell lysate with MAEL antibody at 1 ug/mL.](http://images.novusbio.com/fullsize/MAEL-Antibody-Western-Blot-NBP1-77139-img0001.jpg "Western Blot: MAEL Antibody [NBP1-77139] - HeLa cell lysate with MAEL antibody at 1 ug/mL.")
![Immunocytochemistry/Immunofluorescence: MAEL Antibody [NBP1-77139] - HeLa cells with MAEL antibody at 5 ug/mL.](http://images.novusbio.com/fullsize/MAEL-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-77139-img0002.jpg)
![Immunocytochemistry/ Immunofluorescence: MAEL Antibody - BSA Free [NBP1-77139] - Immunofluorescence of MAEL in HeLa cells with MAEL antibody at 20 ug/mL.](http://images.novusbio.com/fullsize/nbp1-77139_rabbit-polyclonal-mael-antibody-271120242016961.jpg)
![Western Blot: Cadherin-13 Antibody (OTI3H6) [NBP2-02528] - Analysis of extracts (10ug) from 10 Human tissue by using anti-CDH13 monoclonal antibody at 1:500 (1: Testis; 2: Omentum; 3: Uterus; 4: Breast; 5: Brain; 6: Liver; 7: Ovary; 8: Thyroid gland; 9: colon;10: spleen).](http://images.novusbio.com/fullsize/Cadherin-13-Antibody-OTI3H6-Western-Blot-NBP2-02528-img0008.jpg "Western Blot: Cadherin-13 Antibody (OTI3H6) [NBP2-02528] - Analysis of extracts (10ug) from 10 Human tissue by using anti-CDH13 monoclonal antibody at 1:500 (1: Testis; 2: Omentum; 3: Uterus; 4: Breast; 5: Brain; 6: Liver; 7: Ovary; 8: Thyroid gland; 9: colon;10: spleen).")
![Immunocytochemistry/Immunofluorescence: Cadherin-13 Antibody (OTI3H6) [NBP2-02528] - Staining of COS7 cells transiently transfected by pCMV6-ENTRY Cadherin-13 Antibody (3H6)](http://images.novusbio.com/fullsize/Cadherin-13-Antibody-3H6-Immunocytochemistry-Immunofluorescence-NBP2-02528-img0004.jpg)
![Western Blot: Cadherin-13 Antibody (3H6) [NBP2-02528] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY Cadherin-13 Antibody (3H6 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti- Cadherin-13 Antibody (3H6)](http://images.novusbio.com/fullsize/Cadherin-13-Antibody-3H6-Western-Blot-NBP2-02528-img0006.jpg)
![Immunohistochemistry-Paraffin: PMCA2 Antibody [NB120-3529] - Immunohistochemistry was performed on normal biopsies of deparaffinized Human brain tissue. To expose target proteins, heat induced antigen retrieval was performed using 10mM sodium citrate (pH6.0) buffer, microwaved for 8-15 minutes. Following antigen retrieval tissues were blocked in 3% BSA-PBS for 30 minutes at room temperature. Tissues were then probed at a dilution of 1:200 with a rabbit polyclonal antibody recognizing PMCA2 ATPase or without primary antibody (negative control) overnight at 4C in a humidified chamber. Tissues were washed extensively with PBST and endogenous peroxidase activity was quenched with a peroxidase suppressor. Tissues were counterstained with hematoxylin and prepped for mounting.](http://images.novusbio.com/fullsize/PMCA2-Antibody-Immunohistochemistry-Paraffin-NB120-3529-img0004.jpg "Immunohistochemistry-Paraffin: PMCA2 Antibody [NB120-3529] - Immunohistochemistry was performed on normal biopsies of deparaffinized Human brain tissue. To expose target proteins, heat induced antigen retrieval was performed using 10mM sodium citrate (pH6.0) buffer, microwaved for 8-15 minutes. Following antigen retrieval tissues were blocked in 3% BSA-PBS for 30 minutes at room temperature. Tissues were then probed at a dilution of 1:200 with a rabbit polyclonal antibody recognizing PMCA2 ATPase or without primary antibody (negative control) overnight at 4C in a humidified chamber. Tissues were washed extensively with PBST and endogenous peroxidase activity was quenched with a peroxidase suppressor. Tissues were counterstained with hematoxylin and prepped for mounting.")
![Immunohistochemistry-Paraffin: PMCA2 Antibody [NB120-3529] - Cancer biopsies of deparaffinized Human cervical carcinoma tissue.](http://images.novusbio.com/fullsize/PMCA2-Antibody-Immunohistochemistry-Paraffin-NB120-3529-img0005.jpg)
![Western Blot: SULT2A1 Antibody (4D7) [NBP2-03003] Analysis of extracts (35ug) from 9 different cell lines by using anti-SULT2A1 monoclonal antibody.](http://images.novusbio.com/fullsize/SULT2A1-Antibody-4D7-Western-Blot-NBP2-03003-img0004.jpg "Western Blot: SULT2A1 Antibody (4D7) [NBP2-03003] Analysis of extracts (35ug) from 9 different cell lines by using anti-SULT2A1 monoclonal antibody.")
![Immunocytochemistry/Immunofluorescence: SULT2A1 Antibody (4D7) [NBP2-03003] - Staining of COS7 cells transiently transfected by pCMV6-ENTRY SULT2A1.](http://images.novusbio.com/fullsize/SULT2A1-Antibody-4D7-Immunocytochemistry-Immunofluorescence-NBP2-03003-img0003.jpg)
![Flow Cytometry: SULT2A1 Antibody (4D7) [NBP2-03003] - HEK293T cells transfected with either overexpression plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-SULT2A1 antibody, and then analyzed by flow cytometry.](http://images.novusbio.com/fullsize/SULT2A1-Antibody-4D7-Flow-Cytometry-NBP2-03003-img0001.jpg)
![Western Blot: SULT2A1 Antibody (4D7) [NBP2-03003] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SULT2A1 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SULT2A1.](http://images.novusbio.com/fullsize/SULT2A1-Antibody-4D7-Western-Blot-NBP2-03003-img0002.jpg)